Mavacamten Clinical Trials
9 recruitingDrug
Phase 41
Showing 1–9 of 9 trials
Recruiting
Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Bristol-Myers Squibb362 enrolled1 locationNCT07557498
Recruiting
Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)
Cardiomyopathy
Bristol-Myers Squibb36 enrolled1 locationNCT07541833
Recruiting
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Hypertrophic Cardiomyopathy
Bristol-Myers Squibb500 enrolled15 locationsNCT07361289
Recruiting
Phase 4
A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
Symptomatic Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb50 enrolled31 locationsNCT07004972
Recruiting
Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Bristol-Myers Squibb200 enrolled1 locationNCT07383025
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb1,600 enrolled99 locationsNCT05489705
Recruiting
Mavacamten Pregnancy Surveillance Program
Hypertrophic CardiomyopathyPregnancy RelatedBreastfeeding
Bristol-Myers Squibb20 enrolled1 locationNCT05939700
Recruiting
Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb118 enrolled1 locationNCT06551129
Recruiting
A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb600 enrolled2 locationsNCT06146660